Diagnostic and Evaluation of Hepato-pancreatico-biliary Disease With MRI
- Conditions
- Liver DiseasesPancreas Disease
- Interventions
- Diagnostic Test: Magnetic resonance imaging
- Registration Number
- NCT04701567
- Lead Sponsor
- University of Zurich
- Brief Summary
This is a retrospective review of images from patient data. There is no recruitment necessary for this study.
Research Question: Can advanced multiparametric MRI techniques improve the detection and characterization of focal and diffuse liver disease, accurately assess treatment response and predict patient outcomes based on longitudinal monitoring? Hypotheses: Advanced multiparametric MRI techniques improve the detection, characterization and response assessment of focal and diffuse liver disease and can predict serious liver related outcomes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
- Patients with suspicion for or diagnosed focal and/or diffuse liver or pancreatic disease who underwent MRI of the abdomen.
- 18 years of age and older.
Exclusion Criteria
- Age less than 18 years.
- Lack of MRI of the abdomen.
- Inadequate image quality.
- Documented rejection to participate in research studies
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Pancreatic disease Magnetic resonance imaging - Liver disease Magnetic resonance imaging -
- Primary Outcome Measures
Name Time Method Pathology findings in focal and/or diffuse liver disease 1 year Pathology findings in focal and/or diffuse liver disease
Pathology findings in focal and/or diffuse pancreatic disease 1 year Pathology findings in focal and/or diffuse pancreatic disease
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital Zurich
🇨ðŸ‡Zurich, Switzerland